NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages 228-235

  Volpe, Vincenzo ^a   Raia, Zelinda ^a   Sanguigno, Luca ^a   Somma, Domenico ^a   Mastrovito, Paola ^a   Moscato, Fortunato ^b   Mellone, Stefano ^b   Leonardi, Antonio ^a   Pacifico, Francesco ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN TARGETING; THYROID CARCINOMA;

ACUTE-PHASE PROTEINS; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; LIPOCALINS; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 84872070271     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2528     Document Type: Article

References (32)

1. Gupta GP, Massagué J 2006 Cancer metastasis: building a framework. Cell 127:679-695
2. Steeg PS 2006 Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895-904
3. Kessenbrock K, Plaks V, Werb Z 2010 Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52-67
4. Bauvois B 2012 New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 1825:29-36
5. Klein G, Vellenga E, Fraaije MW, Kamps WA, de Bont ES 2004 The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 50:87-100
6. Turpeenniemi-Hujanen T 2005 Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie (Paris) 87:287-297
7. Yu XF, Han ZC 2006 Matrix metalloproteinases in bone marrow: roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies. Histol Histopathol 21:519-531
8. Rydlova M, Holubec Jr L, Ludvikova Jr M, Kalfert D, Franekova J, Povysil C, Ludvikova M 2008 Biological activity and clinical implications of the matrix metalloproteinases. Anticancer Res 28:1389-1397
9. Yan L, Borregaard N, Kjeldsen L, Moses MA 2001 The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276:37258-37265
10. Pacifico F, Mauro C, Barone C, Crescenzi E, Mellone S, Monaco M, Chiappetta G, Terrazzano G, Liguoro D, Vito P, Consiglio E, Formisano S, Leonardi A 2004 Oncogenic and anti-apoptotic activity of NF-κB in human thyroid carcinomas. J Biol Chem 279:54610-54619
11. Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C, Tell G, Salzano AM, Scaloni A, Vuttariello E, Chiappetta G, Formisano S, Leonardi A 2008 The neutrophil gelatinase-associated lipocalin (NGAL), aNF-κB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci USA 105:14058-14063
12. Flower DR, North AC, Sansom CE 2000 The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta 1482:9-24
13. Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM, Gould MN 1998 Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer 79:565-572
14. Friedl A, Stoesz SP, Buckley P, Gould MN 1999 Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 31:433-441
15. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L 1996 Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38:414-420
16. Bartsch S, Tschesche H 1995 Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett 357:255-259
17. Furutani M, Arii S, Mizumoto M, Kato M, Imamura M 1998 Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett 122:209-214
18. Fernández CA, Yan L, Louis G, Yang J, Kutok JL, Moses MA 2005 The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11:5390-5395
19. Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van Duijn W, Zuidwijk K, van der Reijden JJ, Hanemaaijer R, Griffioen G, Lamers CB, Verspaget HW 2007 Clinical evidence for a protective role of lipocalin-2 against MMP-9 auto degradation and the impact for gastric cancer. Eur J Cancer 43:1869-1876
20. Zhang H, Xu L, Xiao D, Xie J, Zeng H, Wang Z, Zhang X, Niu Y, Shen Z, Shen J, Wu X, Li E 2007 Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumor invasion. J Clin Pathol 60:555-561
21. Nuntagowat C, Leelawat K, Tohtong R 2010 NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation. Clin Exp Metastasis 27:295-305
22. Coles M, Diercks T, Muehlenweg B, Bartsch S, Zölzer V, Tschesche H, Kessler H 1999 The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin. J Mol Biol 289:139-157
23. Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, Feig B, Zhang W, Pusztai L, Symmans WF, Wu Y, Arlinghaus RB 2009 Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res 69:8579-8584
24. Lin CW, Tseng SW, Yang SF, Ko CP, Lin CH, Wei LH, Chien MH, Hsieh YS 2012 Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer. Oral Dis 18:734-740
25. Hiromoto T, Noguchi K, Yamamura M, Zushi Y, Segawa E, Takaoka K, Moridera K, Kishimoto H, Urade M 2011 Up-regulation of neutrophil gelatinase-associated lipocalin in oral squamous cell carcinoma: relation to cell differentiation. Oncol Rep 26:1415-1421
26. Roy R, Louis G, Loughlin KR, Wiederschain D, Kilroy SM, Lamb CC, Zurakowski D, Moses MA 2008 Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin Cancer Res 14:6610-6617
27. Zhang XF, Zhang Y, Zhang XH, Zhou SM, Yang GG, Wang OC, Guo GL, Yang GY, Hu XQ 2009 Clinical significance of Neutrophil gelatinase-associated lipocalin (NGAL) expression in primary rectal cancer. BMC Cancer 9:134
28. Pacifico F, Crescenzi E, Mellone S, Iannetti A, Porrino N, Liguoro D, Moscato F, Grieco M, Formisano S, Leonardi A 2010 Nuclear factor-κB contributes to anaplastic thyroid carcinomas through upregulation of miR-146a. J Clin Endocrinol Metab 95:1421-1430
29. Pacifico F, Leonardi A 2010 Role of NF-κB in thyroid cancer. Mol Cell Endocrinol 321:29-35
30. Pacifico F, Paolillo M, Chiappetta G, Crescenzi E, Arena S, Scaloni A, Monaco M, Vascotto C, Tell G, Formisano S, Leonardi A 2007 RbAp48 is a target of nuclear factor-κB activity in thyroid cancer. J Clin Endocrinol Metab 92:1458-1466
31. Pacifico F, Leonardi A 2006 NF-κB in solid tumors. Biochem Pharmacol 72:1142-1152
32. Andela VB, Schwarz EM, Puzas JE, O'Keefe RJ, Rosier RN 2000 Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor κB. Cancer Res 60:6557-6562